FDA approves expanded use of Bristol-Myers' skin cancer drug
November 24, 2015 at 07:31 AM EST
Nov 24 (Reuters) - Bristol-Myers Squibb Co said the U.S. Food and Drug Administration had approved the expanded use of its cancer drug, Opdivo, to treat an additional form of advanced skin cancer.
